Overcoming the Dangerous Intersection of Opioids, Chronic Pain, & Misuse
Credit Available - See Credits tab below.
Total Credits: 3.5 AMA PRA Category 1 Credit, 3.5 AOA Category 1-A CME Credit
- Average Rating:
- 14
- Categories:
- ER/LA | Controlled Substance Prescribing
- Faculty:
- Snigdha Ancha, M.D. | Jonathan A. Benfield, D.O. | John A. Kriak, Pharm.D.
- Course Levels:
- Intermediate
- Duration:
- 3 Hours 30 Minutes
- Format:
- Audio and Video
- License:
- Product Setting: Expires 60 day(s) after program date.
Description
A 3.5 hour virtual educational event covering risk evaluation and mitigation strategies for controlled substance prescribing of Extended Release/Long Acting Opioid Analgesics. This course meets the Department of Occupational and Professional Licensing requirements for physician license renewal in Utah.
Financial Relationship Disclosure to Learners: No one involved in planning or presenting this activity has any relevant financial relationships to disclose.
Grievance Policy Here
Credits
AMA Credit Designation Statement:
Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this live activity for a maximum of 3.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) and Noorda College of Osteopathic Medicine. MAOPS is accredited by the ACCME to provide continuing medical education for physicians.
AOA Credit Designation Statement:
The Utah Osteopathic Medical Association is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The Utah Osteopathic Medical Association designates this program for a maximum of 1 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
Handouts
| Credit Access (382.2 KB) | Available after Purchase | ||
| CDC Guidelines (713.8 KB) | Available after Purchase | ||
| Naloxone Administration (292.4 KB) | Available after Purchase | ||
| REMS Patient Counseling Guide (1.1 MB) | Available after Purchase | ||
| Slides (13.9 MB) | Available after Purchase | ||
| Windows of Drug Detection (111.6 KB) | Available after Purchase | ||
Faculty
Snigdha Ancha, M.D. Related Seminars and Products
Pain Specialist
Jonathan A. Benfield, D.O. Related Seminars and Products
Clinical Preceptor
Intermountain Utah Valley Pain Management
